164 related articles for article (PubMed ID: 10483367)
1. HIV reverse transcriptase inhibitors of natural origin.
Matthée G; Wright AD; König GM
Planta Med; 1999 Aug; 65(6):493-506. PubMed ID: 10483367
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of inhibition of human immunodeficiency virus type-1 reverse transcriptase by calanolide A.
Currens MJ; Mariner JM; McMahon JB; Boyd MR
J Pharmacol Exp Ther; 1996 Nov; 279(2):652-61. PubMed ID: 8930168
[TBL] [Abstract][Full Text] [Related]
3. Specific inhibition of human immunodeficiency virus type 1 reverse transcriptase mediated by soulattrolide, a coumarin isolated from the latex of calophyllum teysmannii.
Pengsuparp T; Serit M; Hughes SH; Soejarto DD; Pezzuto JM
J Nat Prod; 1996 Sep; 59(9):839-42. PubMed ID: 8864237
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HIV-1 reverse transcriptase and HIV-1 replication by Calophyllum coumarins and xanthones.
Dharmaratne HR; Tan GT; Marasinghe GP; Pezzuto JM
Planta Med; 2002 Jan; 68(1):86-7. PubMed ID: 11842340
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
[TBL] [Abstract][Full Text] [Related]
6. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum.
Kashman Y; Gustafson KR; Fuller RW; Cardellina JH; McMahon JB; Currens MJ; Buckheit RW; Hughes SH; Cragg GM; Boyd MR
J Med Chem; 1992 Jul; 35(15):2735-43. PubMed ID: 1379639
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 inhibitory compounds from Calophyllum brasiliense leaves.
Huerta-Reyes M; Basualdo Mdel C; Abe F; Jimenez-Estrada M; Soler C; Reyes-Chilpa R
Biol Pharm Bull; 2004 Sep; 27(9):1471-5. PubMed ID: 15340243
[TBL] [Abstract][Full Text] [Related]
8. Screening of selected plant extracts for in vitro inhibitory activity on HIV-1 reverse transcriptase (HIV-1 RT).
Mlinaric A; Kreft S; Umek A; Strukelj B
Pharmazie; 2000 Jan; 55(1):75-7. PubMed ID: 10683878
[TBL] [Abstract][Full Text] [Related]
9. Novel HIV-1 reverse transcriptase inhibitors.
Jochmans D
Virus Res; 2008 Jun; 134(1-2):171-85. PubMed ID: 18308412
[TBL] [Abstract][Full Text] [Related]
10. Structural analogues of the calanolide anti-HIV agents. Modification of the trans-10,11-dimethyldihydropyran-12-ol ring (ring C).
Zembower DE; Liao S; Flavin MT; Xu ZQ; Stup TL; Buckheit RW; Khilevich A; Mar AA; Sheinkman AK
J Med Chem; 1997 Mar; 40(6):1005-17. PubMed ID: 9083491
[TBL] [Abstract][Full Text] [Related]
11. Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives.
Campiani G; Ramunno A; Maga G; Nacci V; Fattorusso C; Catalanotti B; Morelli E; Novellino E
Curr Pharm Des; 2002; 8(8):615-57. PubMed ID: 11945162
[TBL] [Abstract][Full Text] [Related]
12. Designing anti-AIDS drugs targeting the major mechanism of HIV-1 RT resistance to nucleoside analog drugs.
Sarafianos SG; Hughes SH; Arnold E
Int J Biochem Cell Biol; 2004 Sep; 36(9):1706-15. PubMed ID: 15183339
[TBL] [Abstract][Full Text] [Related]
13. Progress of bis(heteroaryl)piperazines (BHAPs) as non-nucleoside reverse transcriptase inhibitors (NNRTIs) against human immunodeficiency virus type 1 (HIV-1).
Xu H
Mini Rev Med Chem; 2010 Jan; 10(1):62-72. PubMed ID: 20380641
[TBL] [Abstract][Full Text] [Related]
14. The effect of NNRTIs on HIV reverse transcriptase dimerization.
Tachedjian G; Goff SP
Curr Opin Investig Drugs; 2003 Aug; 4(8):966-73. PubMed ID: 14508881
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches.
Tarrago-Litvak L; Andreola ML; Fournier M; Nevinsky GA; Parissi V; de Soultrait VR; Litvak S
Curr Pharm Des; 2002; 8(8):595-614. PubMed ID: 11945161
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 reverse transcriptase inhibitors.
El Safadi Y; Vivet-Boudou V; Marquet R
Appl Microbiol Biotechnol; 2007 Jun; 75(4):723-37. PubMed ID: 17370068
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors.
Gawali R; Trivedi J; Bhansali S; Bhosale R; Sarkar D; Mitra D
Eur J Med Chem; 2018 Sep; 157():310-319. PubMed ID: 30099253
[TBL] [Abstract][Full Text] [Related]
18. Natural Plant Alkaloid (Emetine) Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity.
Chaves Valadão AL; Abreu CM; Dias JZ; Arantes P; Verli H; Tanuri A; de Aguiar RS
Molecules; 2015 Jun; 20(6):11474-89. PubMed ID: 26111177
[TBL] [Abstract][Full Text] [Related]
19. TSAO compounds: the comprehensive story of a unique family of HIV-1 specific inhibitors of reverse transcriptase.
Camarasa MJ; San-Félix A; Velázquez S; Pérez-Pérez MJ; Gago F; Balzarini J
Curr Top Med Chem; 2004; 4(9):945-63. PubMed ID: 15134550
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening, identification, and biochemical characterization of novel inhibitors of the reverse transcriptase of human immunodeficiency virus type-1.
Herschhorn A; Hizi A
J Med Chem; 2008 Sep; 51(18):5702-13. PubMed ID: 18800765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
